VECTIVBIO HLDG AG's ticker is VECT and the CUSIP is H9060V101. A total of 29 filers reported holding VECTIVBIO HLDG AG in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2023 | $315,304 | -1.7% | 37,051 | 0.0% | 0.23% | -9.9% |
| Q4 2022 | $320,862 | +44.5% | 37,051 | 0.0% | 0.25% | +180.0% |
| Q3 2022 | $222,000 | +11.0% | 37,051 | 0.0% | 0.09% | +26.8% |
| Q2 2022 | $200,000 | +14.3% | 37,051 | 0.0% | 0.07% | -2.7% |
| Q1 2022 | $175,000 | -3.8% | 37,051 | 0.0% | 0.07% | +55.3% |
| Q4 2021 | $182,000 | – | 37,051 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,782,199 | $20,424,000 | 7.80% |
| CAXTON CORP | 194,577 | $1,051,000 | 1.41% |
| Cormorant Asset Management, LP | 2,840,389 | $15,338,000 | 1.16% |
| Novo Holdings A/S | 3,339,484 | $18,033,000 | 0.89% |
| Orbimed Advisors | 6,473,561 | $34,957,000 | 0.63% |
| Bpifrance SA | 2,806,217 | $15,154,000 | 0.57% |
| Eventide Asset Management | 2,339,044 | $12,631,000 | 0.27% |
| Tekla Capital Management LLC | 756,502 | $4,085,000 | 0.16% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 865,229 | $4,672,000 | 0.08% |
| Canaan Partners XI LLC | 37,051 | $200,000 | 0.07% |